Therapy News and Research

RSS

Salk research in yeast leads to serendipitous finding about hypomyelinating leukodystrophy

Studying the fundamental aspects of biology can sometimes lead to unexpected findings that directly relate to human disease. In one of the latest examples of scientific serendipity, researchers from the Salk Institute found that an important quality control mechanism in baker's yeast is closely connected to hypomyelinating leukodystrophy, a debilitating disease found in children.

17 Sep 2018

New program combines basic science and social benefits to address HIV risk among young women

A program established by investigators from the Ragon Institute of Massachusetts General Hospital, MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from two angles - first, investigating biological factors that modulate infection risk along with the early immunologic events following viral exposure, and second, alleviating the socioeconomic factors that limit opportunities for young women, the group at greatest risk of infection in the region of the world hardest hit by the HIV epidemic.

17 Sep 2018

Short-term psychotherapy improves mental health of women caring for children with chronic conditions

Brief cognitive behavioral therapy significantly improved the mental health of women overwhelmed by caring for children with severe chronic health conditions, researchers at the University of Louisville have found.

14 Sep 2018

New device to treat acute coronary artery perforations approved by FDA

The U.S. Food and Drug Administration today approved a device intended to treat acute coronary artery perforations, or tears in the blood vessels of the heart. The PK Papyrus Covered Coronary Stent System is the first device approved by the FDA for this indication in 17 years.

14 Sep 2018

Previously unknown virus acts as 'driver' for interstitial nephropathy

An international research team led by Wolfgang Weninger, who has been Head of MedUni Vienna's Department of Dermatology since 1 September, has discovered a previously unknown virus that acts as a "driver" for certain kidney diseases (interstitial nephropathy).

14 Sep 2018

The Digital Health Platform That’s Tackling Chronic Health Conditions

An interview with Simon Pickup from Liva Healthcare about the Liva digital health platform and how it is changing the lives of patients with chronic diseases.

From Liva Healthcare UK 14 Sep 2018

Study: Testosterone replacement therapy may slow disease progression in COPD patients

Researchers from The University of Texas Medical Branch at Galveston found that testosterone replacement therapy may slow disease progression of chronic obstructive pulmonary disease. The paper is currently available in Chronic Respiratory Disease.

14 Sep 2018

Obesity changes airway muscle function, raises asthma risk

New research suggests that obesity changes how airway muscles function, increasing the risk of developing asthma. The study is published ahead of print in the American Journal of Physiology--Lung Cellular and Molecular Physiology.

14 Sep 2018

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Rush University Medical Center is part of a new clinical trial testing whether an experimental vaccine can help patients' immune systems stop the spread of glioblastoma -- an aggressive form of brain cancer with veryhttps://www.rush.edu/news/press-releases/rush-testing-new-brain-cancer-vaccine few current treatment options.

14 Sep 2018

Studies explore biological mechanisms that may explain HIV post-treatment controllers

Most HIV patients need to take daily anti-retroviral therapy - if they suspend treatment, HIV will rebound within 3-4 weeks.

14 Sep 2018

Discovery of key mechanism may lead to more functional skin grafts for burn victims

University of Colorado Boulder researchers have discovered a key mechanism by which skin begins to develop in embryos, shedding light on the genetic roots of birth defects like cleft palate and paving the way for development of more functional skin grafts for burn victims.

14 Sep 2018

Novel treatment for hairy cell leukemia approved by FDA

The U.S. Food and Drug Administration today approved Lumoxiti (moxetumomab pasudotox-tdfk) injection for intravenous use for the treatment of adult patients with relapsed or refractory hairy cell leukemia (HCL) who have received at least two prior systemic therapies, including treatment with a purine nucleoside analog.

14 Sep 2018

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Scientists at the Research Institute of the McGill University Health Centre (RI-MUHC) have identified new means of fighting drug-tolerant bacteria, a growing global threat as menacing as drug-resistant microbes.

14 Sep 2018

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

Two new studies by scientists at Scripps Research are bringing Ebola virus's weaknesses into the spotlight, showing for the first time exactly how human and mouse antibodies can bind to the virus and stop infection--not only for Ebola virus, but for other closely related pathogens as well.

13 Sep 2018

Is ‘precision medicine’ the answer to cancer? Not precisely.

Facing incurable breast cancer at age 55, MaryAnne DiCanto put her faith in "precision medicine" — in which doctors try to match patients with drugs that target the genetic mutations in their tumors. She underwent repeated biopsies to identify therapies that might help.

13 Sep 2018

Study: Poor older Americans most likely to rely on prescription opioids

Among older Americans, the poorest are the most likely to have used prescription opioids, according to a University at Buffalo study providing new insights into unexplored contours of the opioid crisis.

12 Sep 2018

Highly personalized approach may help immune cells to eliminate melanoma

With new immunotherapy treatments for melanoma, recovery rates have risen dramatically, in some cases to around 50%.

12 Sep 2018

Cellular environment affects type of tumor development

Liver cancer is the second leading cause of cancer death worldwide. Two different forms of primary liver cancer cover the majority of cases: About 10 to 20 percent of those affected develop a bile duct carcinoma within the liver (intrahepatic cholangiocellular carcinoma; ICC), the far higher proportion of liver cancers are hepatocellular carcinomas.

12 Sep 2018

Research shows novel approach for treatment of myocardial infarction

Myocardial infarction - commonly known as a heart attack - is still one of the main causes of death. According to the Federal Statistical Office, more than 49,00 people died of its consequences.

12 Sep 2018

Doctor to the stars disciplined over use of controversial menopause therapy

In a conversation with Sarah “Fergie” Ferguson, the Duchess of York, that aired on the Oprah Winfrey Network, Dr. Prudence Hall said age isn't what determines health and vitality.

12 Sep 2018

Therapy News and Research

Salk research in yeast leads to serendipitous finding about hypomyelinating leukodystrophy

New program combines basic science and social benefits to address HIV risk among young women

Short-term psychotherapy improves mental health of women caring for children with chronic conditions

New device to treat acute coronary artery perforations approved by FDA

Previously unknown virus acts as 'driver' for interstitial nephropathy

The Digital Health Platform That’s Tackling Chronic Health Conditions

Study: Testosterone replacement therapy may slow disease progression in COPD patients

Obesity changes airway muscle function, raises asthma risk

New clinical trial initiated on experimental vaccine to stop the spread of glioblastoma

Studies explore biological mechanisms that may explain HIV post-treatment controllers

Discovery of key mechanism may lead to more functional skin grafts for burn victims

Novel treatment for hairy cell leukemia approved by FDA

Researchers identify mechanism that could make pathogens more susceptible to antibiotics

Rare antibodies could be key ingredients in therapeutics capable of neutralizing many Ebola types

Is ‘precision medicine’ the answer to cancer? Not precisely.

Study: Poor older Americans most likely to rely on prescription opioids

Highly personalized approach may help immune cells to eliminate melanoma

Cellular environment affects type of tumor development

Research shows novel approach for treatment of myocardial infarction

Doctor to the stars disciplined over use of controversial menopause therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News